+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe Neuromodulation Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Technology Neuromodulation, and Internal Neuromodulation; Application (Chronic Pain Management, Failed Back Syndrome, Epilepsy, Tremor, Incontinence, Depression, Dys

  • ID: 5231461
  • Report
  • November 2020
  • Region: Europe
  • 117 pages
  • The Insight Partners
UP TO OFF
until Jan 31st 2021
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott
  • Magstim
  • Medtronic
  • NeuroPace, Inc.
  • NeuroSigma, Inc.
  • NEVRO CORP.
  • MORE
According to the latest study on ‘Europe Neuromodulation Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Technology, Application, End User, and Country’ the Europe Neuromodulation market was valued at US$ 2,296.33 million in 2019 and is projected to reach US$ 4,741.75 million by 2027; it is expected to grow at a CAGR of 9.8% during 2020-2027. The report highlights the trends prevailing in the Europe neuromodulation market and the factors driving the market along with those that act as deterrents to its growth.

Based on technology, the neuromodulation market is segmented external (non-invasive) neuromodulation and internal neuromodulation. In 2019, the internal neuromodulation segment accounted for the largest share of the Europe neuromodulation market. The growth of the segment attributes to growth of internal neuromodulation segment is attributed to increasing product launches in the market, the rising product innovation for neuromodulation devices and growing developments in neuromodulation technology are some of the primary factors contributing to the dominance of the segment in the Europe Neuromodulation market. Additionally, the outbreak of the COVID-19 pandemic has highly affected the countries in the European region.

Abbott, Boston Scientific Corporation, Medtronic, NeuroPace, Inc., NeuroSigma, Inc., NEVRO CORP, Synapse Biomedical Inc., Soterix Medical Inc, Integer Holdings Corporation, and Magstim. are among the prominent players present in the neuromodulation market. The market players are focused on mergers and acquisitions to sustain their position in the market. For instance, in September 2020 Boston Scientific announced the European launch of the WaveWriter Alpha portfolio of Spinal Cord Stimulator (SCS) Systems. The portfolio, consisting of four MRI conditional, Bluetooth-enabled implantable pulse generators (IPGs), offers expanded personalization based on patient needs, including rechargeable and non-rechargeable options, and access to waveforms that can cover multiple areas of pain.

The report segments the Europe neuromodulation market as follows:

By Technology
  • External (Non-Invasive) Neuromodulation
  • Respiratory Electrical Stimulation
  • Transcutaneous Electrical Nerve Stimulation
  • Transcranial Magnetic Stimulation
  • Internal Neuromodulation
  • Deep Brain Stimulation
  • Sacral Nerve Stimulation
  • Gastric Electrical Stimulation
  • Spinal Cord Stimulation
  • Vagus Nerve Stimulation
By Application
  • Chronic Pain Management
  • Failed Back Syndrome
  • Epilepsy
  • Tremor
  • Incontinence
  • Depression
  • Dystonia
  • Gastroparesis
  • Parkinson’s Disease
  • Obsessive-Compulsive Disorder
  • Migraine
By End User
  • Hospitals
  • Clinics
  • Home Healthcare
By Country
  • UK
  • Germany
  • France
  • Italy
  • Spain
Reasons to Buy
  • Saves and reduces time required for carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe neuromodulation market
  • Highlights key business priorities to assist companies in order to realign their business strategies
  • Highlights key findings and recommendations of crucial progressive industry trends in the European neuromodulation market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develops/modifies business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinizes in-depth European market trends and outlook coupled with the factors driving the market, as well as those hindering it
  • Enhances the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott
  • Magstim
  • Medtronic
  • NeuroPace, Inc.
  • NeuroSigma, Inc.
  • NEVRO CORP.
  • MORE
1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Neuromodulation Market - by Technology
1.3.2 Neuromodulation Market - by Application
1.3.3 Neuromodulation Market - by End User
1.3.4 Europe Neuromodulation Market - by Country

2. Neuromodulation Market - Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Neuromodulation- Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Expert Opinions

5. Neuromodulation Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Incidence of Neurological Disorders
5.1.2 Growing Developments in Neuromodulation Technology
5.2 Market Restraints
5.2.1 High Cost of Neuromodulation Devices
5.3 Market Opportunities
5.3.1 Rising Demand for Neurostimulation Devices to Treat Chronic Pain
5.4 Future Trends
5.4.1 Technological Advancements
5.5 Impact Analysis

6. Neuromodulation Market Analysis - by Technology
6.1 Overview
6.2 Neuromodulation Market Share, by Technology, 2019 and 2027 (%)
6.3 External Neuromodulation
6.3.1 Overview
6.3.2 External Neuromodulation: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
6.3.3 Respiratory Electrical Stimulation (RES)
6.3.3.1 Overview
6.3.3.2 Respiratory Electrical Stimulation: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
6.3.4 Transcutaneous Electrical Nerve Stimulation (TENS)
6.3.4.1 Overview
6.3.4.2 Transcutaneous Electrical Nerve Stimulation (TENS): Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
6.3.5 Transcranial Magnetic Stimulation (TMS)
6.3.5.1 Overview
6.3.5.2 Transcranial Magnetic Stimulation (TMS): Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
6.4 Internal Neuromodulation
6.4.1 Overview
6.4.2 Internal Neuromodulation: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
6.4.3 Deep Brain Stimulation (DBS)
6.4.3.1 Overview
6.4.3.2 Deep Brain Stimulation: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
6.4.4 Sacral Nerve Stimulation (DBS)
6.4.4.1 Overview
6.4.4.2 Sacral Nerve Stimulation: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
6.4.5 Gastric Electric Stimulation (GES)
6.4.5.1 Overview
6.4.5.2 Gastric Electric Stimulation (GES): Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
6.4.6 Spinal Cord Stimulation (SCS)
6.4.6.1 Overview
6.4.6.2 Spinal Cord Stimulation (SCS): Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
6.4.7 Vagus Nerve Stimulation (VNS)
6.4.7.1 Overview
6.4.7.2 Vagus Nerve Stimulation (VNS): Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)

7. Neuromodulation Market Analysis - by Application
7.1 Overview
7.2 Neuromodulation Market Share, by Application, 2019 and 2027 (%)
7.3 Chronic Pain Management
7.3.1 Overview
7.3.2 Chronic Pain Management: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
7.4 Failed Back Syndrome
7.4.1 Overview
7.4.2 Failed Back Syndrome: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
7.5 Epilepsy
7.5.1 Overview
7.5.2 Epilepsy: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
7.6 Tremor
7.6.1 Overview
7.6.2 Tremor: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
7.7 Incontinence
7.7.1 Overview
7.7.2 Incontinence: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
7.8 Depression
7.8.1 Overview
7.8.2 Depression: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
7.9 Dystonia
7.9.1 Overview
7.9.2 Dystonia: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
7.10 Gastroparesis
7.10.1 Overview
7.10.2 Gastroparesis: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
7.11 Parkinson’s Disease
7.11.1 Overview
7.11.2 Parkinson’s Disease: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
7.12 Obsessive-Compulsive Disorder (OCD)
7.12.1 Overview
7.12.2 Obsessive-Compulsive Disorder: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
7.13 Migraine
7.13.1 Overview
7.13.2 Migraine: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)

8. Neuromodulation Market Analysis - by End User
8.1 Overview
8.2 Neuromodulation Market Share, by End User, 2019 and 2027, (%)
8.3 Hospitals
8.3.1 Overview
8.3.2 Hospitals: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
8.4 Clinics
8.4.1 Overview
8.4.2 Clinics: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
8.5 Home Healthcare
8.5.1 Overview
8.5.2 Home Healthcare: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)

9. Neuromodulation Market Analysis and Forecasts to 2027 - Regional Analysis
9.1 Europe: Neuromodulation Market
9.1.1 Overview
9.1.2 Europe: Neuromodulation Market, - Revenue and Forecast to 2027 (USD Million)
9.1.3 Europe: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
9.1.3.1 Europe: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.1.3.2 Europe: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.1.4 Europe: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
9.1.5 Europe: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
9.1.6 Europe: Neuromodulation Market, by Country, 2019 & 2027 (%)
9.1.7 Germany: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
9.1.7.1 Germany: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
9.1.7.2 Germany: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
9.1.7.2.1 Germany: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.1.7.2.2 Germany: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.1.7.3 Germany: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
9.1.7.4 Germany: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
9.1.8 UK: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
9.1.8.1 UK: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
9.1.8.2 UK: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
9.1.8.2.1 UK: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.1.8.2.2 UK: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.1.8.3 UK: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
9.1.8.4 UK: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
9.1.9 France: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
9.1.9.1 France: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
9.1.9.2 France: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
9.1.9.2.1 France: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.1.9.2.2 France: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.1.9.3 France: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
9.1.9.4 France: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
9.1.10 Spain: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
9.1.10.1 Spain: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
9.1.10.2 Spain: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
9.1.10.2.1 Spain: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.1.10.2.2 Spain: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.1.10.3 Spain: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
9.1.10.4 Spain: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
9.1.11 Italy: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
9.1.11.1 Italy: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
9.1.11.2 Italy: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
9.1.11.2.1 Italy: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.1.11.2.2 Italy: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.1.11.3 Italy: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
9.1.11.4 Italy: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)

10. Impact of COVID-19 Pandemic on Europe Neuromodulation Market
10.1 Europe: Impact Assessment of COVID-19 Pandemic

11. Company Profiles
11.1 Abbott
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Boston Scientific Corporation
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Medtronic
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 NeuroSigma, Inc.
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Nevro Corp.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Synapse Biomedical Inc.
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Soterix Medical Inc
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Integer Holdings Corporation
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Magstim
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments

12. Appendix
12.1 Glossary of Terms

List of Tables
Table 1. North America: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 2. North America: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 3. North America: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 4. North America: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 5. North America: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 6. US: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 7. US: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 8. US: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 9. US: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 10. US: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 11. Canada: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 12. Canada: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 13. Canada: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 14. Canada: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 15. Canada: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 16. Mexico: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 17. Mexico: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 18. Mexico: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 19. Mexico: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 20. Mexico: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 21. Europe: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 22. Europe: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 23. Europe: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 24. Europe: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 25. Europe: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 26. Germany: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 27. Germany: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 28. Germany: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 29. Germany: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 30. Germany: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 31. UK: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 32. UK: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 33. UK: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 34. UK: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 35. UK: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 36. France: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 37. France: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 38. France: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 39. France: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 40. France: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 41. Spain: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 42. Spain: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 43. Spain: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 44. Spain: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 45. Spain: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 46. Italy: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 47. Italy: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 48. Italy: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 49. Italy: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 50. Italy: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 51. Asia Pacific: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 52. Asia Pacific: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 53. Asia Pacific: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 54. Asia Pacific: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 55. Asia Pacific: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 56. China: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 57. China: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 58. China: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 59. China: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 60. China: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 61. Japan: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 62. Japan: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 63. Japan: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 64. Japan: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 65. Japan: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 66. India: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 67. India: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 68. India: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 69. India: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 70. India: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 71. South Korea: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 72. South Korea: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 73. South Korea: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 74. South Korea: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 75. South Korea: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 76. Australia: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 77. Australia: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 78. Australia: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 79. Australia: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 80. Australia: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 81. Middle East and Africa: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 82. Middle East and Africa: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 83. Middle East and Africa: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 84. Middle East and Africa: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 85. Middle East and Africa: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 86. Saudi Arabia: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 87. Saudi Arabia: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 88. Saudi Arabia: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 89. Saudi Arabia: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 90. Saudi Arabia: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 91. UAE: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 92. UAE: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 93. UAE: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 94. UAE: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 95. UAE: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 96. South Africa: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 97. South Africa: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 98. South Africa: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 99. South Africa: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 100. South Africa: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 101. South and Central America: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 102. South and Central America: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 103. South and Central America: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 104. South and Central America: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 105. South and Central America: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 106. Brazil: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 107. Brazil: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 108. Brazil: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 109. Brazil: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 110. Brazil: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 111. Argentina: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 112. Argentina: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 113. Argentina: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 114. Argentina: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 115. Argentina: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 116. Organic Developments Done by Companies
Table 117. Inorganic Developments Done by Companies
Table 118. Glossary of Terms, Neuromodulation Market

List of Figures
NA
Note: Product cover images may vary from those shown
3 of 3
  • Abbott
  • Boston Scientific Corporation
  • Medtronic
  • NeuroPace, Inc.
  • NeuroSigma, Inc.
  • NEVRO CORP.
  • Synapse Biomedical Inc.
  • Soterix Medical Inc
  • Integer Holdings Corporation
  • Magstim
Note: Product cover images may vary from those shown
Adroll
adroll